ProMIS Neurosciences Inc PMN

Management and the future

[goldtech]

Although I have no love for this pathetic board of Directors and know the Goldstein and Williams have manipulated the Directors to their will, I am optimistic Dr.Cashman has the holy grail and will prove it. We can bash management, ridiculous financings, crazy dilution, but you CANNOT dispute the science and where we are going now. For those who say they have sold, great, now go away and share your great trade with your family, or your neighbor, but go away. For those long and strong the next few months will be exciting.

[Normandt]

well said goldtech

[IIIIIIIIIIIIIIl]

Thumbs up..Anyone who ever finds a cure or way to slow down this disease is going to be a very popular company and profitable....Having experienced the death of a loved one very recently to this disease and see it firsthand I give these guys credit for trying to solve it..If they are  even remotely successful on the way forward shareholders here will prosper.Those who sold made there few

[FarmerBetty]

Time to consider it's the science not management or bod's. How many years they have been at this and they can't get any pharma deals? Lot's of smart pharma people out there and if it was the holy grail you  pharma would license it no matter how competent board or mpt is . Not to mention ALS and PD programs will be dead in the water if AD results not favorable. Could be last

[M101]

An argument every long time holder will have pondered more than once, but the history of scientific breakthroughs argues otherwise and the underlying reason hasn't changed: human nature.

[Speculativefool]

The PMN technology and its potential has been well known via countless conferences etc for several years, yet no big company appears to see this and want to partner with us or buy us out... This tells me that the science is still very speculative. That's why this remains a penny stock (now in Nasdaq clothing). So can someone tell us why a big pharma or biotech corp hasn't swallowed us up

[Speculativefool]

OR have I answered my own question?

[BottomBroker]

All questions will be answered via Phase I (and hopefully Phase 2 and Phase 3) trials.  Why is this so hard for people to understand?

[Speculativefool]

But the point is, BB, that no one has stepped up to partner in funding a phase 1... The question is then, why not? Surely it's not just about what's fashionable (as one of my respondents said) nor is it all about the assumed manipulations of the Boston bros who know that there's nothing to the science (as another responded)... Bottom line appears to be that no one in the industry

[BottomBroker]

No, the point is that we have 6-12 months more to wait to find out if PMN has what they seem to think they have. If they do, then we, as shareholders, will benefit. If not, then the gamble is lost. And that's all this really is. A gamble. 

[M101]

If you're waiting for a big pharma player to take the lead then "Speculativefool" is not an ideal user name. And how did you arrive at a statement about scientific feasibility?

[M101]

Yes, the lack of partnering is an issue. M&A not so much since no one is going to shell out $1B+ for a company with no human trial results in a field where rats have been unreliable. But I've yet to discover any big pharma player touting its cutting edge research into protein misfolding. The CNS field has been dominated by players exploring natural drugs, or their modified variants, which

[DavidKingCanada]

Because PMN has already sold its soul to the Boston Group who are not interested in the Science (which any company can copy) but rather diluting the Shares and making a quick buck and exiting. Diluted Shares 60-1 Reverse Split PMN has NOTHING special, it's been 15 years and nothing. All lies and people on this forum have lost their life savings.  No one is interested in a small

[IFlyTheUnicorn]

This post has been removed in accordance with Community Policy